• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NSB

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD

9.09% ! 18.0¢
Market Cap $59.86M  !
Healthcare Biotechnology
Add to My Watchlist

NeuroScientific Biopharmaceuticals Limited is an Australia-based company, which is... NeuroScientific Biopharmaceuticals Limited is an Australia-based company, which is engaged in developing peptide-based pharmaceutical drugs that target a number of neurodegenerative conditions with high unmet medical demand. The Company's product portfolio includes EmtinB, a therapeutic peptide initially targeting glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn and EmtinBn). EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body's innate immune response to cell injury. Its StemSmart is a global patented technology engaged in manufacturing cell products. The use of its proprietary StemSmart technology in a special access program for fistulising Crohn’s disease.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NSB
Ann: Date of AGM & Closing Date for Director Nominations 		16/09/25 0 112
16/09/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  112 
NSB
Ann: Notification regarding unquoted securities - NSB 		16/09/25 0 85
16/09/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  85 
NSB
Ann: Previous StemSmart Studies Support Renal Transplantation 		08/09/25 6 1.2K
08/09/25 Last post  Meme68 Comments Created with Sketch.  6  Views Created with Sketch.  1.2K 
NSB
Ann: Appendix 4G & Corporate Governance Statement 		28/08/25 0 132
28/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  132 
NSB
Ann: 2025 Annual Report & Appendix 4E 		28/08/25 0 155
28/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  155 
NSB
People are waking up to stemsmart 		24/08/25 18 7.4K
24/08/25 Last post  Focker Comments Created with Sketch.  18  Views Created with Sketch.  7.4K 
NSB
Ann: Presentation - TechKnow Invest Roadshow Conference 		19/08/25 0 270
19/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  270 
NSB
Ann: NeuroScientific Partners with Leading Biologic Manufacturer 		13/08/25 5 2.4K
13/08/25 Last post  ozz1 Comments Created with Sketch.  5  Views Created with Sketch.  2.4K 

See All Discussions arrow Created with Sketch.

Timeline

Date of AGM & Closing Date for Director Nominations
16 Sep 09:46
 
Notification regarding unquoted securities - NSB
16 Sep 09:28
 
Appendix 4G & Corporate Governance Statement
28 Aug 17:23
 
2025 Annual Report & Appendix 4E
28 Aug 17:23
 
Previous StemSmart Studies Support Renal Transplantation
27 Aug 09:49
 
Presentation - TechKnow Invest Roadshow Conference
19 Aug 08:47
 
View More arrow Created with Sketch.

Featured News

RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
NEWS Gateway acquires interest in strategic Glenburgh South Gold Project in WA
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
3DA Amaero’s big move: Exclusive deal, big targets, and a lot on the line
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
18.0¢ 		Change
0.015(9.09%) 		Mkt cap ! $59.86M
Open High Low Value Volume
17.5¢ 18.0¢ 17.0¢ $89.52K 510.3K

Buyers (Bids)

No. Vol. Price($)
1 50000 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 69933 3
View Market Depth
Last trade - 16.10pm 17/09/2025 (20 minute delay) ?
NSB (ASX) Chart

Top Stories

Listen: HotCopper Wire Podcast 025 – Locksley rap video gives Hilltop Hoods run for money

Welcome to this week’s HotCopperWire, our market watch podcast! Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through the week’s biggest news headlines @ and what they mean for Oz investors.In this Week 38 epis...
Market Close: The US Fed rate is one thing – but are FDI outflows bringing down a boring ASX in favour of Wall Street? Good Afternoon and welcome to Market Close for Wednesday 17 September, I’m Jon Davidson. The market’s nervous, that much is clear, putting the ASX in line with Asian peers. We get the Fed rate cut decision on Friday Australia time, and it looked like profit takers ...
Nearly a year later, Ovanti revives Nasdaq talks after a BNPL revival in the US Microcap fintech BNPL player Ovanti, currently a penny stock, has revived its nearly 12-month-long plans to list on the Nasdaq.
SILEX eyeing one-year breakeven as latest uranium uptick supports updates on enrichment testing SILEX Systems has jumped +13% on Wednesday as wider global uranium stocks on the whole continue to enjoy a risk-on week.
Painchek sees modest gain on reports aged care monitoring app bodes well in Scottish pilot Painchek has seen support for its value prop on the back of a Scottish trial that used its 'Adult App' in the "Scottish care system."

Featured News

NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
NEWS Gateway acquires interest in strategic Glenburgh South Gold Project in WA
right-arrow Created with Sketch.
NEWS Locksley significantly enlarges exploration program after historical discovery
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.